1. Home
  2. LPCN vs AZI Comparison

LPCN vs AZI Comparison

Compare LPCN & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • AZI
  • Stock Information
  • Founded
  • LPCN 1997
  • AZI 2010
  • Country
  • LPCN United States
  • AZI China
  • Employees
  • LPCN N/A
  • AZI N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • AZI
  • Sector
  • LPCN Health Care
  • AZI
  • Exchange
  • LPCN Nasdaq
  • AZI Nasdaq
  • Market Cap
  • LPCN 13.8M
  • AZI 11.4M
  • IPO Year
  • LPCN N/A
  • AZI 2024
  • Fundamental
  • Price
  • LPCN $3.18
  • AZI $0.07
  • Analyst Decision
  • LPCN Strong Buy
  • AZI
  • Analyst Count
  • LPCN 1
  • AZI 0
  • Target Price
  • LPCN $7.00
  • AZI N/A
  • AVG Volume (30 Days)
  • LPCN 54.7K
  • AZI 59.5M
  • Earning Date
  • LPCN 11-06-2025
  • AZI 01-01-0001
  • Dividend Yield
  • LPCN N/A
  • AZI N/A
  • EPS Growth
  • LPCN N/A
  • AZI N/A
  • EPS
  • LPCN N/A
  • AZI N/A
  • Revenue
  • LPCN $4,322,693.00
  • AZI $156,466,000.00
  • Revenue This Year
  • LPCN N/A
  • AZI N/A
  • Revenue Next Year
  • LPCN N/A
  • AZI N/A
  • P/E Ratio
  • LPCN N/A
  • AZI N/A
  • Revenue Growth
  • LPCN N/A
  • AZI 32.90
  • 52 Week Low
  • LPCN $2.52
  • AZI $0.06
  • 52 Week High
  • LPCN $5.50
  • AZI $1.93
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 61.21
  • AZI 31.37
  • Support Level
  • LPCN $3.07
  • AZI $0.06
  • Resistance Level
  • LPCN $3.32
  • AZI $0.13
  • Average True Range (ATR)
  • LPCN 0.20
  • AZI 0.02
  • MACD
  • LPCN 0.06
  • AZI 0.00
  • Stochastic Oscillator
  • LPCN 65.82
  • AZI 10.99

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.

Share on Social Networks: